Effects of nefopam with fentanyl in intravenous patient-controlled analgesia after arthroscopic orthopedic surgery: a prospective double-blind randomized trial
- Authors
- Oh, You Na; Kim, Kyu Nam; Jeong, Mi Ae; Kim, Dong Won; Kim, Ji Yoon; Ki, Hyun Seo
- Issue Date
- 2018
- Publisher
- TUBITAK SCIENTIFIC & TECHNICAL RESEARCH COUNCIL TURKEY
- Keywords
- Analgesia; balanced; analgesia; patient-controlled; nefopam; randomized controlled trial
- Citation
- TURKISH JOURNAL OF MEDICAL SCIENCES, v.48, no.1, pp.142 - 149
- Indexed
- SCIE
SCOPUS
- Journal Title
- TURKISH JOURNAL OF MEDICAL SCIENCES
- Volume
- 48
- Number
- 1
- Start Page
- 142
- End Page
- 149
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/150866
- DOI
- 10.3906/sag-1707-113
- ISSN
- 1300-0144
- Abstract
- Background/aim: We performed this prospective randomized double-blind study to compare the effects of nefopam versus ketorolac in intravenous fentanyl-based patient-controlled analgesia (PCA) after shoulder arthroscopic orthopedic surgery. Materials and methods: Ninety-two patients were randomly divided into two groups to receive intravenous PCA. Patients were assigned to either the nefopam group (nefopam 120 mg and fentanyl 20 mu g/kg) or the ketorolac group (ketorolac 2 mg/kg and fentanyl 20 mu g/kg). Pain was assessed on a visual analogue scale (VAS) and a numeric rating scale (NRS). Additionally, patient satisfaction, adverse events, and vital signs were monitored. Results: There were no significant differences in VAS score (P = 0.48) or NRS score (P = 0.15) between the two groups. Similarly, patient satisfaction did not differ between the two groups [8.5(0.8) vs. 8.2(1.0), P = 0.14]. There were no statistically significant differences in the incidence of nausea (P = 0.72), vomiting (P = 0.46), urinary retention (P = 0.82), sweating (P = 0.49), or dizziness (P = 0.45) between the two groups. Likewise, there were no differences in heart rate [78.2(7.7) vs. 75.2(6.5), P = 0.18] or SpO2 [98.4(1.8) vs. 98.5(1.9), P = 0.83]. Conclusion: Nefopam is an appropriate alternative for co-administration with fentanyl-based PCA in patients who have difficulty using nonsteroidal antiinflammatory drugs.
- Files in This Item
-
Go to Link
- Appears in
Collections - 서울 의과대학 > 서울 마취통증의학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/150866)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.